QIAGEN N.V. (QGEN) stock
QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$49.75−0.06 (-0.12%)
Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%
Qiagen EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Qiagen's EV/EBITDA was 17.5× on Nov 11, 2026, against 38.3× a year earlier. Over the last 5 years it ranged from 12.3× to 40.9×, with a median of 15.6×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 17.5× | −18.6 |
| 2025 | Dec 31, 2025 | 36.1× | +18.7 |
| 2024 | Dec 31, 2024 | 17.4× | +2.6 |
| 2023 | Dec 29, 2023 | 14.8× | −0.6 |
| 2022 | Dec 30, 2022 | 15.5× | −9.8 |
| 2021 | Dec 31, 2021 | 25.2× | −40.8 |
| 2020 | Dec 31, 2020 | 66.1× | +46.8 |
| 2019 | Dec 31, 2019 | 19.2× | −5.6 |
| 2018 | Dec 31, 2018 | 24.8× | −1.8 |
| 2017 | Dec 29, 2017 | 26.7× | +6.0 |
| 2016 | Dec 30, 2016 | 20.7× | −0.5 |
| 2015 | Dec 31, 2015 | 21.2× | −3.4 |
| 2014 | Dec 31, 2014 | 24.6× | +7.4 |
| 2013 | Dec 31, 2013 | 17.1× | −0.8 |
| 2012 | Dec 31, 2012 | 18.0× | −2.0 |
| 2011 | Jan 31, 2011 | 19.9× | −1.2 |
| 2010 | Dec 31, 2010 | 21.1× | −2.6 |
| 2009 | Dec 31, 2009 | 23.7× | – |
See a number that looks wrong?